AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

Recruitingn/aAges 21 Years - 70 YearsAllJens Titze
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The study aims to provide quantitative facts on the pathophysiological changes in tissue Na+ content during Na+/K+ redistribution disorders in patients with PA in response to standard therapy. The investigators hypothesize that patients with primary aldosteronism have excessive Na+ storage in the muscle, which can now be quantified non-invasively using 23NaMRI. In analogy to the role of HbA1c as a metabolic long-term marker in diabetes, the quantifiable changes in muscle Na+ content may deliver the data evidence necessary to justify and conduct randomized diagnostic endpoint outcome trials in the future, with the ultimate aim to improve PA detection rate and treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age 21-70 years, with arterial hypertension or suspected to have primary aldosteronism based on Endocrine Society Guidelines. 2. Male and female patients older than 21 years. 3. Willingness to participate and ability to provide informed consent. Exclusion Criteria: 1. Patients with exclusion criteria for the MRI, such as: * implanted devices (surgical clips, heart pacemakers or defibrillators, cochlear implants) * iron-based tattoos * any other pieces of metal or devices that are not MR-Safe anywhere in the body * patients who exhibit noticeable anxiety and/or claustrophobia into the MRI scanner * pregnancy 2. Diagnosis of heart failure NYHA classes III and IV 3. Impaired renal function with eGFR\<30 ml/min or proteinuria \> 1 g/24h 4. Liver disease with cirrhosis (Child-Pugh class C) or hypoalbuminemia 5. Muscular dystrophies 6. Patients with active cancer or severe comorbid conditions likely to compromise survival or study participation 7. Unwillingness or other inability to cooperate
๐Ÿ’Š

What it tests

  • 23NaMRI Scan
  • Potassium Chloride (KCl)
๐Ÿ“

Where

4 sites
Singapore General Hospital
Singapore, Singapore
Duke NUS Medical School
Singapore, Singapore
Changi General Hospital
Singapore, Singapore
Sengkang General Hospital
Singapore, Singapore
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy